Skip to content

Local applicationnof durva ointment and indravaruni ointment in the management of Shudhha vrana

Comparative study to evaluate efficacy of durva ointment and indravaruni oint in management of shuddha vran - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100917
Enrollment
56
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L76- Intraoperative and postproceduralcomplications of skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Shubham Udhavrao Wayal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having healthy granulated wound.

Exclusion criteria

Exclusion criteria: Gangrenous wound Neoplastic ulcers Burn Arterial ulcer Bed sores Varicose ulcers Immunocompromised patients

Design outcomes

Primary

MeasureTime frame
To study the efficacy of durva ointment in management of Shudhha vranaTimepoint: Total Duration will be 18 months

Secondary

MeasureTime frame
To Observe the duration required for the complete healing of shudhha vrana To study the rate of healing in Shudhha vrana To see the adverse effect of durva ointmentTimepoint: Total duration will be 18 months

Countries

India

Contacts

Public ContactDr Kamalakar V Gajare

MAMs Sumatibhai shah ayurved mahavidyalaya Hadapsar Pune

drgajarekv@gmail.com9822071732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026